Patents by Inventor Moussa S. Diarra

Moussa S. Diarra has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210393762
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: August 24, 2021
    Publication date: December 23, 2021
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • Publication number: 20210322532
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: June 25, 2021
    Publication date: October 21, 2021
    Inventors: Francois MALOUIN, Marianne ALLARD, Christian LEBEAU JACOB, Brian Geoffrey TALBOT, Daniel SCHOLL, Pierre LACASSE, Moussa S. DIARRA, Celine STER
  • Patent number: 11129884
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: September 28, 2021
    Assignee: SOCPRA—SCIENCES ET GENIE, s.e.c.
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • Patent number: 11065322
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: January 22, 2020
    Date of Patent: July 20, 2021
    Assignee: SOCPRA—SCIENCES ET GENIE, s.e.c.
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • Publication number: 20200188501
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0442, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: January 22, 2020
    Publication date: June 18, 2020
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • Publication number: 20200147197
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: January 22, 2020
    Publication date: May 14, 2020
    Inventors: FRANCOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CELINE STER
  • Patent number: 10576139
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: June 20, 2018
    Date of Patent: March 3, 2020
    Assignee: SOCPRA—SCIENCES ET GÉNIE, s.e.c.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Publication number: 20180289791
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: June 20, 2018
    Publication date: October 11, 2018
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Patent number: 10029004
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: November 7, 2016
    Date of Patent: July 24, 2018
    Assignee: SOCPRA—SCIENCES ET GÉNIE, S.E.C.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Publication number: 20170095548
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: November 7, 2016
    Publication date: April 6, 2017
    Inventors: FRANÇOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CÉLINE STER
  • Patent number: 9566322
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: February 14, 2017
    Assignee: SOCPRA—SCIENCES ET GÉNIE, S.E.C.
    Inventors: François Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Céline Ster
  • Publication number: 20150132335
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: October 14, 2014
    Publication date: May 14, 2015
    Inventors: FRANÇOIS MALOUIN, MARIANNE ALLARD, CHRISTIAN LEBEAU JACOB, BRIAN GEOFFREY TALBOT, DANIEL SCHOLL, PIERRE LACASSE, MOUSSA S. DIARRA, CÉLINE STER
  • Publication number: 20130064845
    Abstract: Agents, compositions, methods and kits useful for the treatment and diagnosis of Staphylococcal intramammary infection are disclosed. The agents, compositions, methods and kits are derived from genes expressed during Staphylococcal intramammary infection, and more particularly genes SACOL0029, SACOL0264, SACOL0442, SACOL0718, SACOL0720, SACOL1353, SACOL1416, SACOL1611, SACOL1944, SACOL2144, SACOL2365 or SACOL2599, based on the gene nomenclature from the Staphylococcus aureus COL (SACOL) genome.
    Type: Application
    Filed: March 17, 2011
    Publication date: March 14, 2013
    Inventors: Francois Malouin, Marianne Allard, Christian Lebeau Jacob, Brian Geoffrey Talbot, Daniel Scholl, Pierre Lacasse, Moussa S. Diarra, Celine Ster
  • Publication number: 20080207491
    Abstract: The present invention relates to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increase susceptibility and can reverse resistance of microorganism to antibiotics.
    Type: Application
    Filed: October 31, 2007
    Publication date: August 28, 2008
    Inventors: Moussa S. Diarra, Pierre Lacasse, Denis Petitclerc
  • Publication number: 20030134779
    Abstract: The present invention relates to a new composition, use and method to improve the cure of infections caused by antibiotic resistant microbial pathogens, in particular beta-lactam resistant microorganisms. Lactoferrin (LF) or Lactoferricin (LFC) can be administrated alone or in combination with antibiotic to affect growth, physiology and morphology of targeted microorganism. Lactoferrin increase susceptibility and can reverse resistance of microorganism to antibiotics.
    Type: Application
    Filed: September 23, 2002
    Publication date: July 17, 2003
    Inventors: Moussa S. Diarra, Pierre Lacasse, Denis Petitclerc